Moreover, 5AZA2 treatment combined with anti-CTLA-4 is synergistic in murine mammary carcinoma TS/A and in mesothelioma AB1 models and results in high CD8+ and CD4+ T cell infiltration (146). The gene discussed is CTLA4; the disease is breast carcinoma.